Federal contractors / SACHI BIOWORKS, INC.

Federal contract award

80NSSC24CA006

SBIR PHASE III - REVERSING IMMUNE DYSREGULATION DURING SPACEFLIGHT MISSIONS

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyNational Aeronautics and Space Administration
OfficeNASA SHARED SERVICES CENTER
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCAJ14 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; R&D ADMINISTRATIVE EXPENSES
Parent award / vehicleNot reported
Set-asideSMALL BUSINESS SET ASIDE - TOTAL
Pricing typeFIRM FIXED PRICE
Obligations$2.2M
Current contract value$2.2M
Potential contract value / ceiling$2.2M
Start dateMar 18, 2024
Current end dateMar 17, 2026
Potential end dateMar 17, 2026
Latest award activityJan 6, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jan 6, 2026P00005$0SBIR PHASE III - REVERSING IMMUNE DYSREGULATION DURING SPACEFLIGHT MISSIONS
Aug 18, 2025P00004$520.1KSBIR PHASE III - REVERSING IMMUNE DYSREGULATION DURING SPACEFLIGHT MISSIONS
Mar 6, 2025P00003$553.8KSBIR PHASE III - REVERSING IMMUNE DYSREGULATION DURING SPACEFLIGHT MISSIONS
Aug 22, 2024P00002$380.4KSBIR PHASE III - REVERSING IMMUNE DYSREGULATION DURING SPACEFLIGHT MISSIONS
Apr 30, 2024P00001$380.4KSBIR PHASE III - REVERSING IMMUNE DYSREGULATION DURING SPACEFLIGHT MISSIONS
Mar 18, 20240$400.0KSBIR PHASE III - REVERSING IMMUNE DYSREGULATION DURING SPACEFLIGHT MISSIONS

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.